This week was quiet on the trading front - no new buys or sells.
Want to stay on top of the market trends? Our Momentum Ranking report highlights the top stocks of the week, so you don’t have to! Click here to access the latest data for week 40.
This Week’s Trading Activity: Updates and Insights
This week has been relatively quiet in our trading landscape. The S&P 500 remains strong, sitting above its 200-day moving average for 229 consecutive days now. This suggests a bullish market environment, allowing for potential new buys and rebalancing opportunities, following the adjusted slope momentum strategy as described by Andreas Clenow in “Stocks On The Move.”
Buys, Sells, and Rebalancing Activity
Despite the favorable market conditions, there were no new transactions this week. Our portfolio did not introduce any new buys, and we remained firm with our existing positions. Additionally, the Barrons 400 index was updated last week, but this rebalancing did not trigger any trades for us.
Speaking of sectors, cash continues to dominate the majority of our portfolio. Holding cash reserves in such times allows us to stay flexible for any rapid market changes or opportunities. Among our existing holdings, Corcept Therapeutics (CORT) and United Therapeutics (UTHR) stand out as top holdings.
Top Performers and Portfolio Health
Reflecting on performance, Corcept Therapeutics has been our best performer over the last seven trading days, with a gain of 9.54%. On the flip side, Texas Pacific Land Corporation (TPL) faced a setback, recording a loss of 5.50%. Despite these fluctuations, our strategic approach still keeps us resilient in navigating the ebb and flow of the market.
Closing Thoughts
In summary, while no new buys or sells occurred this week, our portfolio remains well-positioned with a significant portion in cash and strong performers like CORT and UTHR holding fort. The market environment continues to be monitored closely, with all actions remaining in line with our momentum ranking strategy.
Feel free to share your thoughts or questions in the comments below. We’d love to hear how you’re navigating these market conditions and any insights or queries you might have. Happy trading!
This week’s transactions:
-
Sold:
- No sells in this week!
-
Bought:
- No buys in this week!
-
Rebalanced / added:
- No positions were added to in this week!
-
Rebalanced / reduced:
- No positions were reduced in this week!
Index Distribution:
At the moment, we are holding mostly cash:
Current portfolio allocation:
There’s not a lot going on in the portfolio right now, just a lot of cash sitting around:
Weekly sector distribution:
Current portfolio (@finviz):
| Symbol | Name | Index | Sector | MC | Dist to 52w High | pct |
|---|---|---|---|---|---|---|
| cash | Cash | Cash | Cash | – | 199466 | 0.925 |
| CORT | Corcept Therapeutics Inc | Barrons 400 | Healthcare | 4.80B | -2.87% | 0.015 |
| UTHR | United Therapeutics Corp | S&P 400 | Healthcare | 15.84B | -2.72% | 0.015 |
| TPL | Texas Pacific Land Corporation | S&P 400 | Energy | 20.77B | -5.79% | 0.012 |
| HALO | Halozyme Therapeutics Inc. | S&P 400 | Healthcare | 7.12B | -14.28% | 0.011 |
| PLTR | Palantir Technologies Inc | S&P 500 | Technology | 81.78B | -4.37% | 0.01 |
| TBBK | Bancorp Inc. | Barrons 400 | Financial Services | 2.48B | -7.89% | 0.007 |
| LNTH | Lantheus Holdings Inc | S&P 400 | Healthcare | 7.51B | -14.79% | 0.006 |
As always, more trades next week!